Netherlands Pharmacovigilance Centre Lareb

本机构学者在这里署名、按本站篇数

合作机构同一篇文章里的其他机构

1. University of Groningen荷兰38
2. Medisch Spectrum Twente荷兰18
3. Radboud University Nijmegen荷兰16
4. Uppsala Monitoring Centre瑞典9
5. Amsterdam UMC Location University of Amsterdam荷兰8
6. Erasmus MC荷兰7
7. Utrecht University荷兰7
8. Reade荷兰7

按月发文

逐年被引

最新文献

1. 1
   Toward a Framework for Case Identification in Pharmacovigilance: Not All Reports are Created EqualDrug Safety20260
2. 2
   Strengthening Signal Detection by Proactive Adverse Event Case Identification in Electronic Health Records Using a Text-Mining ToolDrug Safety20260
3. 3
   Evaluating COVID-19 Vaccine Masking and Unmasking Methods in Two National Pharmacovigilance DatabasesDrug Safety20261
4. 4
   GP Consultations for Venous Thromboembolism ( VTE ) After mRNA and Adeno‐Vector‐Based COVID ‐19 Vaccination—An Exposure‐Anchored Self‐Controlled Cohort Study Based on Primary Healthcare Data From the NetherlandsPharmacoepidemiology and Drug Safety20261
5. 5
   GP Consultations for Herpes Zoster After COVID-19 Vaccination: A Self-Controlled Cohort Study Based on Electronic Health Record Data from the NetherlandsDrug Safety20253
6. 6
   Temporal Changes in Reporting of Neurodevelopmental Outcomes After Maternal Exposure to Valproate: A Contribution of the ConcePTION ProjectDrug Safety20250
7. 7
   Impact of Regulatory Action on Dose Maximalization for Vitamin B6 Dietary Supplements on the Reporting Pattern for NeuropathyPharmacoepidemiology and Drug Safety20255
8. 8
   An Integrated Approach for Representing Knowledge on the Potential of Drugs to Cause Acute Kidney InjuryDrug Safety20249
9. 9
   Qualitative Interviews with Stakeholders in Herbal Pharmacovigilance and Recommendations for Best Practices to be Applied WorldwideDrug Safety20249
10. 10
    The burden of adverse drug reactions reported by patients in the Dutch ADR monitor: a proof of conceptExpert Opinion on Drug Safety20243

高被引文献

1. 1
   ADR Reporting by the General Public: Lessons Learnt from the Dutch and Swedish SystemsDrug Safety201576
2. 2
   Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?Drug Safety201674
3. 3
   What Future Healthcare Professionals Need to Know About Pharmacovigilance: Introduction of the WHO PV Core Curriculum for University Teaching with Focus on Clinical AspectsDrug Safety201870
4. 4
   Sex Differences in Adverse Drug Reactions of Metformin: A Longitudinal Survey StudyDrug Safety202068
5. 5
   Comparative Assessment of the National Pharmacovigilance Systems in East Africa: Ethiopia, Kenya, Rwanda and TanzaniaDrug Safety202065
6. 6
   Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring CentreDrug Safety201758
7. 7
   Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine BrandsDrug Safety202256
8. 8
   Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADRDrug Safety201954
9. 9
   Vitamin B6 in Health Supplements and Neuropathy: Case Series Assessment of Spontaneously Reported CasesDrug Safety201848
10. 10
    The contribution of direct patient reported ADRs to drug safety signals in the Netherlands from 2010 to 2015Pharmacoepidemiology and Drug Safety201737

主要发表期刊

研究主题